Yesterday, the President of Novavax (NVAX), Gregory Glenn, sold shares of NVAX for $59.45K.
This is Glenn’s first Sell trade following 5 Buy transactions. Following Gregory Glenn’s last NVAX Sell transaction on May 13, 2019, the stock climbed by 1.8%.
See today’s analyst top recommended stocks >>
The company has a one-year high of $51.60 and a one-year low of $4.01. Currently, Novavax has an average volume of 858.47K.
Gregory Glenn’s trades have generated a 11.1% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Novavax, Inc. is a late-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology.
Read More on NVAX:
